Lobe Sciences Ltd. (CVE:LOBE) | Finanzwire

Basculer en Français

9773	Companies
195566	Keywords
126551	Articles
103964	Press releases

Home
Companies
Lobe Sciences Ltd.

BRIEF

published on 07/17/2025 at 04:00, 6 months 12 days ago

Lobe Sciences Ltd. Settles Debt with Gibbsons P.C.

Common Shares Issuance Debt Settlement Biopharmaceutical Company Canadian Securities Innovative Treatments
PRESS RELEASE

published on 07/17/2025 at 03:55, 6 months 12 days ago

Lobe Sciences Ltd. Announces Debt Settlement
Lobe Sciences settles debt with Gibbsons Law P.C. by issuing 546,206 common shares at CAD$0.02123/share. The shares were issued on May 13, 2025, subject to regulatory hold periods

Common Shares Debt Settlement Biopharmaceutical Lobe Sciences Regulatory Hold Periods
BRIEF

published on 07/08/2025 at 06:06, 6 months 21 days ago

Lobe Sciences Secures European Patent for Sickle Cell Disease Treatment

European Patent Sickle Cell Disease DHA Composition Altemia® Biopharmaceutical Expansion
PRESS RELEASE

published on 07/08/2025 at 06:01, 6 months 21 days ago

Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
Lobe Sciences secures European Unitary Patent EP4117446 across 17 EU member states for innovative Altemia(R) Medical Food Formula designed to manage Sickle Cell Disease, supporting global expansion strategy

Global Expansion Lobe Sciences Sickle Cell Disease European Unitary Patent Altemia Medical Food Formula
BRIEF

published on 06/18/2025 at 06:03, 7 months 11 days ago

Lobe Sciences Advances Conjugated Psilocin Development with Cynaptec Spin-Out

Conjugated Psilocin Cynaptec Pharmaceuticals Chronic Cluster Headaches Sickle Cell Disease Biopharmaceutical Investments
PRESS RELEASE

published on 06/18/2025 at 05:58, 7 months 11 days ago

Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
Lobe Sciences Ltd. advances Conjugated Psilocin™ research for chronic cluster headaches and addiction via $6M investment in Cynaptec Pharmaceuticals, with option for additional $20M

Clinical Trials Investment Cynaptec Pharmaceuticals Lobe Sciences Ltd. Conjugated Psilocin™
BRIEF

published on 06/03/2025 at 12:15, 7 months 26 days ago

Lobe Sciences Appoints Yong Yao as CFO for Strategic Initiatives

Strategic Growth Operational Expansion Biotech Finance Lobe Sciences Yong Yao
PRESS RELEASE

published on 06/03/2025 at 12:10, 7 months 26 days ago

Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth
Lobe Sciences Ltd. appoints Mr. Yong Yao as CFO & EVP, leveraging his 25 years of finance & biotech experience to drive financial strategy & growth. Strategic shift to full-time financial leadership

Chief Financial Officer Executive Vice President Finance Strategy Lobe Sciences Yong Yao
BRIEF

published on 04/14/2025 at 13:05, 9 months 15 days ago

Lobe Sciences Initiates Private Placement for Drug Development

Private Placement Clinical Trials Lobe Sciences Conjugated Psilocin Cynaptec Pharmaceuticals
PRESS RELEASE

published on 04/14/2025 at 13:00, 9 months 15 days ago

Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
Lobe Sciences announces US$6M private placement for Cynaptec to fund Conjugated Psilocin development. Option for additional US$20M included. Company focuses on lipid tech for orphan diseases

Private Placement Lobe Sciences Lipid Technology Conjugated Psilocin Cynaptec

Accesswire

Published on 01/30/2026 at 00:00, 41 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 1 hour 41 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 5 hours 56 minutes ago

Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 6 hours 41 minutes ago

PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/29/2026 at 17:00, 7 hours 41 minutes ago

Sparta Reports on Delay in Filing Annual Financial Statements

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 00:07, 33 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 3 hours 38 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 3 hours 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/29/2026 at 20:59, 3 hours 41 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 01/29/2026 at 20:57, 3 hours 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 01/29/2026 at 18:00, 6 hours 41 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 6 hours 56 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 6 hours 56 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 7 hours 1 minute ago

ALTEN: Annual revenue 2025
Published on 01/29/2026 at 10:07, 14 hours 33 minutes ago

Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech

View all LES ECHOS COMFI WIRE